Financial Ratios Thermo Fisher Scientific, Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 04:02:53 2026-01-14 pm EST			5-day change	1st Jan Change
625.76 ^USD	+3.08%		+0.72%	+7.27%

Jan. 13	Thermo Fisher wins contracts as pharma shifts production to US, CEO says	RE
Jan. 13	Thermo Fisher Scientific Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM

1f107c61c911f0ae8a8712e311c.-p-xkslZu7iG5OzMPla1rsqmbRSMGHy1LhNN6kh2OkU.t-fw164M2PrErIqCWCfFzKXtP22-ajiCW2I6uwU-aQ6Q8sv1gBPuwdS3mw

Published financial data: THERMO FISHER SCIENTIFIC, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	32.22B	39.21B	44.92B	42.86B	42.88B
Total Revenues	32.22B	39.21B	44.92B	42.86B	42.88B
Cost of Goods Sold, Total	16.21B	19.57B	25.92B	25.74B	25.13B
Gross Profit	16.01B	19.64B	19B	17.11B	17.75B
Selling General & Admin Expenses, Total	6.96B	8B	8.94B	8.38B	8.6B
R&D Expenses	1.18B	1.41B	1.47B	1.34B	1.39B
Other Operating Expenses	-	3M	-	1M	30M
Other Operating Expenses, Total	8.14B	9.41B	10.41B	9.72B	10.02B
Operating Income	7.87B	10.23B	8.59B	7.39B	7.73B
Interest Expense, Total	-553M	-536M	-726M	-1.38B	-1.39B
Interest And Investment Income	65M	43M	272M	879M	1.08B
Net Interest Expenses	-488M	-493M	-454M	-496M	-312M
Income (Loss) On Equity Invest.	-	-4M	-172M	-59M	-42M
Currency Exchange Gains (Loss)	-81M	162M	102M	-29M	-16M
Other Non Operating Income (Expenses)	81M	-161M	-35M	5M	5M
EBT, Excl. Unusual Items	7.38B	9.73B	8.03B	6.82B	7.37B
Restructuring Charges	-18M	-37M	-95M	-233M	-104M
Merger & Related Restructuring Charges	-81M	-35M	-	-	-
Gain (Loss) On Sale Of Investments	10M	66M	-161M	-46M	21M
Gain (Loss) On Sale Of Assets	-	-	14M	-	-
Asset Writedown	-34M	-122M	-60M	-219M	-252M
Legal Settlements	-	-	-	-19M	-
Other Unusual Items	-37M	-767M	-63M	-59M	-39M
EBT, Incl. Unusual Items	7.22B	8.84B	7.66B	6.24B	7B
Income Tax Expense	850M	1.11B	703M	284M	657M
Earnings From Continuing Operations	6.38B	7.73B	6.96B	5.96B	6.34B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	6.38B	7.73B	6.96B	5.96B	6.34B
Minority Interest	-	-3M	-10M	40M	-3M
Net Income - (IS)	6.38B	7.72B	6.95B	6B	6.34B
Net Income to Common Incl Extra Items	6.38B	7.72B	6.95B	6B	6.34B
Net Income to Common Excl. Extra Items	6.38B	7.72B	6.95B	6B	6.34B
Per Share Items
Net EPS - Basic	16.1	19.61	17.73	15.53	16.58
Basic EPS - Continuing Operations	16.1	19.61	17.73	15.53	16.58
Basic Weighted Average Shares Outstanding	396M	394M	392M	386M	382M
Net EPS - Diluted	15.96	19.46	17.63	15.45	16.53
Diluted EPS - Continuing Operations	15.96	19.46	17.63	15.45	16.53
Diluted Weighted Average Shares Outstanding	399M	397M	394M	388M	383M
Normalized Basic EPS	11.66	15.43	12.77	11.14	12.05
Normalized Diluted EPS	11.57	15.31	12.71	11.08	12.02
Dividend Per Share	0.88	1.04	1.2	1.4	1.56
Payout Ratio	5.29	5.11	6.55	8.72	9.2
American Depositary Receipts Ratio (ADR)	0.02	0.02	0.02	0.02	0.02
Supplemental Items
EBITDA	10.2B	12.82B	11.97B	10.8B	10.84B
EBITA	9.54B	11.99B	10.98B	9.73B	9.69B
EBIT	7.87B	10.23B	8.59B	7.39B	7.73B
EBITDAR	10.47B	13.14B	12.43B	11.27B	11.31B
Total Revenues (As Reported)	32.22B	39.21B	44.92B	42.86B	42.88B
Effective Tax Rate - (Ratio)	11.76	12.55	9.17	4.55	9.39
Current Domestic Taxes	696M	606M	1.07B	378M	691M
Current Foreign Taxes	423M	1.15B	633M	1.21B	1.18B
Total Current Taxes	1.12B	1.75B	1.7B	1.58B	1.87B
Deferred Domestic Taxes	-251M	-246M	-683M	-653M	-1.14B
Deferred Foreign Taxes	-18M	-399M	-314M	-647M	-72M
Total Deferred Taxes	-269M	-645M	-997M	-1.3B	-1.21B
Normalized Net Income	4.62B	6.08B	5.01B	4.3B	4.6B
Non-Cash Pension Expense	10M	-6M	-16M	-5M	0
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.18B	1.41B	1.47B	1.34B	1.39B
Net Rental Expense, Total	273M	320M	460M	470M	468M
Imputed Operating Lease Interest Expense	58.78M	46.57M	73.7M	142M	150M
Imputed Operating Lease Depreciation	214M	273M	386M	328M	318M
Stock-Based Comp., Other (Total)	196M	230M	307M	278M	301M
Total Stock-Based Compensation	196M	230M	307M	278M	301M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	10.32B	4.48B	8.52B	8.08B	4.01B
Short Term Investments	-	-	-	-	1.56B
Total Cash And Short Term Investments	10.32B	4.48B	8.52B	8.08B	5.57B
Accounts Receivable, Total	6.47B	8.94B	9.43B	9.66B	9.63B
Other Receivables	-	-	-	-	-
Total Receivables	6.47B	8.94B	9.43B	9.66B	9.63B
Inventory	4.03B	5.05B	5.63B	5.09B	4.98B
Restricted Cash	10M	13M	12M	6M	10M
Other Current Assets, Total	1.12B	1.63B	1.63B	1.75B	1.95B
Total Current Assets	21.96B	20.11B	25.23B	24.59B	22.14B
Gross Property Plant And Equipment	10.35B	14.12B	15.86B	17.08B	17.55B
Accumulated Depreciation	-3.66B	-4.26B	-4.99B	-6.08B	-6.75B
Net Property Plant And Equipment	6.69B	9.86B	10.87B	11B	10.8B
Long-term Investments	53M	63M	154M	45M	438M
Goodwill	26.04B	41.92B	41.2B	44.02B	45.85B
Other Intangibles, Total	12.68B	20.11B	17.48B	16.71B	15.53B
Accounts Receivable Long-Term	11M	9M	7M	4M	6M
Other Long-Term Assets, Total	1.62B	3.04B	2.22B	2.36B	2.56B
Total Assets	69.05B	95.12B	97.15B	98.73B	97.32B
Liabilities
Accounts Payable, Total	2.18B	2.87B	3.38B	2.87B	3.08B
Accrued Expenses, Total	3.84B	5.09B	5.12B	4.52B	4.88B
Short-term Borrowings	-	2.52B	310M	-	-
Current Portion of Long-Term Debt	2.63B	-	5.26B	3.6B	2.2B
Current Portion of Leases	184M	281M	283M	268M	273M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	1.27B	2.66B	2.6B	2.69B	2.85B
Other Current Liabilities	207M	18M	57M	63M	50M
Total Current Liabilities	10.3B	13.44B	17.01B	14.01B	13.33B
Long-Term Debt	19.15B	32.15B	28.8B	31.41B	28.93B
Long-Term Leases	626M	1.39B	1.51B	1.43B	1.43B
Unearned Revenue Non Current	763M	1.24B	1.18B	1.5B	1.14B
Pension & Other Post Retirement Benefits	589M	504M	323M	383M	355M
Deferred Tax Liability Non Current	1.79B	3.84B	2.85B	1.92B	1.27B
Other Non Current Liabilities	1.32B	1.6B	1.34B	1.23B	1.2B
Total Liabilities	34.54B	54.15B	53.01B	51.88B	47.65B
Common Stock, Total	437M	439M	441M	442M	444M
Additional Paid In Capital	15.58B	16.17B	16.74B	17.29B	17.96B
Retained Earnings	28.12B	35.43B	41.91B	47.36B	53.1B
Treasury Stock	-6.82B	-8.92B	-12.02B	-15.13B	-19.23B
Comprehensive Income and Other	-2.81B	-2.33B	-3.1B	-3.22B	-2.7B
Total Common Equity	34.51B	40.79B	43.98B	46.74B	49.58B
Minority Interest	-	184M	170M	107M	87M
Total Equity	34.51B	40.98B	44.15B	46.84B	49.67B
Total Liabilities And Equity	69.05B	95.12B	97.15B	98.73B	97.32B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	394M	391M	385M	381M	377M
ECS Total Common Shares Outstanding	397M	394M	391M	387M	381M
Book Value / Share	86.99	103.42	112.62	120.87	130.22
Tangible Book Value	-4.22B	-21.24B	-14.7B	-13.99B	-11.8B
Tangible Book Value Per Share	-10.64	-53.86	-37.63	-36.19	-30.99
Total Debt	22.59B	36.34B	36.16B	36.71B	32.83B
Net Debt	12.27B	31.86B	27.63B	28.63B	27.26B
Debt Equivalent of Unfunded Proj. Benefit Obligation	361M	284M	259M	335M	310M
Debt Equivalent Oper. Leases	2.18B	2.56B	3.68B	3.76B	3.74B
Minority Interest, Total (Incl. Fin. Div)	-	184M	170M	107M	87M
Equity Method Investments, Total	-	-	-	-	357M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-49M	-	-	-	-
Inventories - Raw Materials, Total	1.3B	1.92B	2.4B	2.06B	1.8B
Inventories - Work In Process, Total	540M	676M	660M	705M	755M
Inventories - Finished Goods, Total	2.18B	2.45B	2.57B	2.33B	2.42B
Land - (BS)	410M	431M	454M	458M	439M
Buildings, Total	2.19B	2.58B	3.15B	3.59B	3.73B
Machinery, Total	6.98B	9.59B	7.97B	9.24B	9.86B
Full Time Employees	80K	130K	130K	122K	125K
Accumulated Allowance for Doubtful Accounts (Supple)	135M	150M	189M	193M	173M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	6.38B	7.72B	6.95B	6B	6.34B
Depreciation & Amortization - CF	658M	831M	986M	1.07B	1.16B
Amortization of Goodwill and Intangible Assets - (CF)	1.67B	1.76B	2.4B	2.34B	1.95B
Depreciation & Amortization, Total	2.32B	2.59B	3.38B	3.41B	3.11B
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	196M	230M	307M	278M	301M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-212M	313M	-435M	-736M	-698M
Change In Accounts Receivable	-1.3B	-204M	-430M	209M	-333M
Change In Inventories	-508M	-1.06B	-825M	598M	-27M
Change In Accounts Payable	59M	479M	648M	-500M	212M
Change in Other Net Operating Assets	1.36B	-758M	-442M	-844M	-231M
Cash from Operations	8.29B	9.31B	9.15B	8.41B	8.67B
Capital Expenditure	-1.47B	-2.52B	-2.24B	-1.48B	-1.4B
Sale of Property, Plant, and Equipment	8M	20M	24M	87M	57M
Cash Acquisitions	-38M	-19.4B	-39M	-3.66B	-3.13B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-1.63B
Other Investing Activities, Total	-6M	-34M	99M	-90M	260M
Cash from Investing	-1.51B	-21.93B	-2.16B	-5.14B	-5.84B
Short Term Debt Issued, Total	383M	2.51B	1.53B	1.62B	-
Long-Term Debt Issued, Total	3.46B	18.14B	3.19B	5.94B	1.2B
Total Debt Issued	3.85B	20.65B	4.72B	7.56B	1.2B
Short Term Debt Repaid, Total	-387M	-	-3.69B	-1.94B	-
Long-Term Debt Repaid, Total	-713M	-11.74B	-375M	-5.78B	-3.61B
Total Debt Repaid	-1.1B	-11.74B	-4.06B	-7.72B	-3.61B
Issuance of Common Stock	196M	156M	-	-	-
Repurchase of Common Stock	-1.5B	-2B	-3B	-3B	-4B
Common Dividends Paid	-337M	-395M	-455M	-523M	-583M
Common & Preferred Stock Dividends Paid	-337M	-395M	-455M	-523M	-583M
Other Financing Activities, Total	-147M	-91M	-9M	56M	194M
Cash from Financing	959M	6.58B	-2.81B	-3.62B	-6.79B
Foreign Exchange Rate Adjustments	176M	194M	-139M	-82M	-91M
Net Change in Cash	7.91B	-5.84B	4.05B	-440M	-4.06B
Supplemental Items
Cash Interest Paid	471M	555M	667M	1.38B	1.57B
Cash Income Tax Paid (Refund)	1.32B	2.18B	1.23B	1.48B	1.83B
Levered Free Cash Flow	5.62B	5.49B	5.82B	5.14B	6.63B
Unlevered Free Cash Flow	5.97B	5.83B	6.27B	6B	7.5B
Change In Net Working Capital	0	863M	543M	826M	-659M
Net Debt Issued / Repaid	2.75B	8.91B	654M	-155M	-2.4B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.72	7.79	5.58	4.72	4.93
Return on Total Capital	9.35	9.51	6.81	5.64	5.82
Return On Equity %	19.87	20.47	16.35	13.09	13.13
Return on Common Equity	19.87	20.52	16.4	13.22	13.15
Margin Analysis
Gross Profit Margin %	49.69	50.08	42.3	39.93	41.39
SG&A Margin	21.59	20.4	19.9	19.56	20.04
EBITDA Margin %	31.65	32.69	26.65	25.2	25.29
EBITA Margin %	29.61	30.58	24.45	22.71	22.59
EBIT Margin %	24.44	26.08	19.12	17.25	18.04
Income From Continuing Operations Margin %	19.79	19.71	15.5	13.9	14.78
Net Income Margin %	19.79	19.7	15.47	13.99	14.77
Net Avail. For Common Margin %	19.79	19.7	15.47	13.99	14.77
Normalized Net Income Margin	14.33	15.5	11.15	10.03	10.73
Levered Free Cash Flow Margin	17.45	14.01	12.95	12	15.47
Unlevered Free Cash Flow Margin	18.52	14.86	13.96	14	17.5
Asset Turnover
Asset Turnover	0.51	0.48	0.47	0.44	0.44
Fixed Assets Turnover	5.31	4.74	4.33	3.92	3.93
Receivables Turnover (Average Receivables)	5.64	5.09	4.89	4.49	4.45
Inventory Turnover (Average Inventory)	4.38	4.31	4.85	4.8	4.99
Short Term Liquidity
Current Ratio	2.13	1.5	1.48	1.75	1.66
Quick Ratio	1.63	1	1.06	1.27	1.14
Operating Cash Flow to Current Liabilities	0.8	0.69	0.54	0.6	0.65
Days Sales Outstanding (Average Receivables)	64.89	71.76	74.65	81.3	82.33
Days Outstanding Inventory (Average Inventory)	83.54	84.66	75.24	76.01	73.3
Average Days Payable Outstanding	44.43	44.68	43.03	45.29	43.53
Cash Conversion Cycle (Average Days)	104	111.74	106.86	112.02	112.1
Long Term Solvency
Total Debt/Equity	65.47	88.68	81.9	78.37	66.1
Total Debt / Total Capital	39.57	47	45.03	43.94	39.79
LT Debt/Equity	57.32	81.84	68.65	70.11	61.12
Long-Term Debt / Total Capital	34.64	43.38	37.74	39.3	36.8
Total Liabilities / Total Assets	50.03	56.92	54.56	52.55	48.96
EBIT / Interest Expense	14.24	19.08	11.83	5.38	5.56
EBITDA / Interest Expense	18.93	24.51	17.12	8.2	8.14
(EBITDA - Capex) / Interest Expense	16.27	19.81	14.03	7.12	7.13
Total Debt / EBITDA	2.16	2.77	2.91	3.26	2.9
Net Debt / EBITDA	1.17	2.42	2.22	2.54	2.41
Total Debt / (EBITDA - Capex)	2.51	3.42	3.55	3.75	3.31
Net Debt / (EBITDA - Capex)	1.36	3	2.71	2.92	2.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.14	21.71	14.55	-4.58	0.05
Gross Profit, 1 Yr. Growth %	41.12	22.68	-3.26	-9.79	3.22
EBITDA, 1 Yr. Growth %	55.96	25.74	-7.68	-9.56	-0.37
EBITA, 1 Yr. Growth %	59.67	25.7	-9.49	-11.16	-1.3
EBIT, 1 Yr. Growth %	84.73	29.95	-17.21	-13.62	3.45
Earnings From Cont. Operations, 1 Yr. Growth %	72.48	21.19	-9.94	-14.44	6.43
Net Income, 1 Yr. Growth %	72.48	21.18	-10.03	-13.74	5.67
Normalized Net Income, 1 Yr. Growth %	90.68	31.77	-18.83	-13.85	5.79
Diluted EPS Before Extra, 1 Yr. Growth %	74.05	21.93	-9.4	-12.37	6.99
Accounts Receivable, 1 Yr. Growth %	30.69	38.21	5.39	2.51	-0.39
Inventory, 1 Yr. Growth %	19.55	25.37	11.54	-9.69	-2.16
Net Property, Plant and Equip., 1 Yr. Growth %	22.74	47.51	10.23	1.2	-1.9
Total Assets, 1 Yr. Growth %	18.28	37.76	2.14	1.62	-1.42
Tangible Book Value, 1 Yr. Growth %	-58.03	403.53	-30.93	-4.79	-15.43
Common Equity, 1 Yr. Growth %	16.28	18.22	7.81	6.27	6.1
Cash From Operations, 1 Yr. Growth %	66.68	12.34	-1.7	-8.17	3.1
Capital Expenditures, 1 Yr. Growth %	59.18	71.17	-11.1	-34.06	-5.34
Levered Free Cash Flow, 1 Yr. Growth %	71.44	-2.26	4.15	-11.34	27.68
Unlevered Free Cash Flow, 1 Yr. Growth %	61.21	-2.31	5.92	-4.03	23.9
Dividend Per Share, 1 Yr. Growth %	15.79	18.18	15.38	16.67	11.43
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.01	23.9	18.07	4.55	-2.29
Gross Profit, 2 Yr. CAGR %	21.37	31.67	8.95	-6.65	-3.27
EBITDA, 2 Yr. CAGR %	28.8	40.84	8.36	-8.73	-4.71
EBITA, 2 Yr. CAGR %	30.28	42.56	7.33	-10.44	-5.97
EBIT, 2 Yr. CAGR %	42.45	56.31	4.48	-15.57	-4.95
Earnings From Cont. Operations, 2 Yr. CAGR %	47.3	44.56	4.47	-12.22	-4.57
Net Income, 2 Yr. CAGR %	47.3	44.57	4.41	-11.91	-4.53
Normalized Net Income, 2 Yr. CAGR %	48.01	60.08	4.21	-16.52	-3.97
Diluted EPS Before Extra, 2 Yr. CAGR %	48.47	45.68	5.1	-10.9	-3.17
Accounts Receivable, 2 Yr. CAGR %	18.68	34.4	20.69	3.94	1.05
Inventory, 2 Yr. CAGR %	15.79	22.43	18.25	0.37	-6
Net Property, Plant and Equip., 2 Yr. CAGR %	26.71	34.56	27.51	5.62	-0.36
Total Assets, 2 Yr. CAGR %	10.81	27.65	18.62	1.88	0.09
Tangible Book Value, 2 Yr. CAGR %	-42.45	45.37	86.64	-18.91	-10.39
Common Equity, 2 Yr. CAGR %	11.84	17.25	12.89	7.04	6.18
Cash From Operations, 2 Yr. CAGR %	35.08	36.84	5.09	-4.99	-2.7
Capital Expenditures, 2 Yr. CAGR %	39.45	65.06	23.36	-23.44	-21
Levered Free Cash Flow, 2 Yr. CAGR %	32.03	30.38	1.74	-4.05	6.96
Unlevered Free Cash Flow, 2 Yr. CAGR %	28.01	26.29	2.53	0.69	9.54
Dividend Per Share, 2 Yr. CAGR %	13.76	16.98	16.77	16.02	14.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.49	17.2	20.7	9.98	3.03
Gross Profit, 3 Yr. CAGR %	18.85	21.8	18.81	2.26	-3.32
EBITDA, 3 Yr. CAGR %	24.74	27.76	22.8	1.95	-5.78
EBITA, 3 Yr. CAGR %	25.6	28.72	23.02	0.69	-7.23
EBIT, 3 Yr. CAGR %	34.7	38.14	27.06	-2.05	-9.32
Earnings From Cont. Operations, 3 Yr. CAGR %	41.97	38.04	23.47	-2.26	-6.4
Net Income, 3 Yr. CAGR %	42.03	38.02	23.43	-2.03	-6.4
Normalized Net Income, 3 Yr. CAGR %	39.76	42.37	28.28	-2.31	-9.3
Diluted EPS Before Extra, 3 Yr. CAGR %	41.78	39.04	24.34	-1.08	-5.29
Accounts Receivable, 3 Yr. CAGR %	18.61	24.86	23.94	14.3	2.48
Inventory, 3 Yr. CAGR %	10.69	18.9	18.68	8.09	-0.48
Net Property, Plant and Equip., 3 Yr. CAGR %	18.22	33.29	25.9	18.06	3.05
Total Assets, 3 Yr. CAGR %	6.81	19.15	18.5	12.66	0.76
Tangible Book Value, 3 Yr. CAGR %	-36.61	18.59	13.49	49.13	-17.84
Common Equity, 3 Yr. CAGR %	10.73	13.93	14.01	10.64	6.72
Cash From Operations, 3 Yr. CAGR %	27.44	27.03	22.55	0.47	-2.36
Capital Expenditures, 3 Yr. CAGR %	42.63	49.31	34.3	0.11	-17.83
Levered Free Cash Flow, 3 Yr. CAGR %	26.49	19.43	21.63	-2.92	5.91
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.76	16.97	19.71	0.2	8.22
Dividend Per Share, 3 Yr. CAGR %	13.62	15.21	16.45	16.74	14.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.69	16.5	16.51	11.96	10.92
Gross Profit, 5 Yr. CAGR %	15.57	18.37	14.78	9.5	9.4
EBITDA, 5 Yr. CAGR %	19.58	23	17.9	11.93	10.9
EBITA, 5 Yr. CAGR %	20.16	23.46	17.93	11.6	10.43
EBIT, 5 Yr. CAGR %	25.77	29.53	21.67	13.77	13.06
Earnings From Cont. Operations, 5 Yr. CAGR %	26.35	30.72	25.59	15.18	11.38
Net Income, 5 Yr. CAGR %	26.41	30.74	25.58	15.33	11.38
Normalized Net Income, 5 Yr. CAGR %	28.42	32.33	24.26	15.33	14.17
Diluted EPS Before Extra, 5 Yr. CAGR %	26.48	30.71	25.78	16.37	12.51
Accounts Receivable, 5 Yr. CAGR %	20.52	24.02	19.43	16.03	14.22
Inventory, 5 Yr. CAGR %	15.13	17.94	13.65	11.11	8.11
Net Property, Plant and Equip., 5 Yr. CAGR %	22.25	30.78	21.86	21.45	14.66
Total Assets, 5 Yr. CAGR %	11.08	15.69	11.38	11.92	10.76
Tangible Book Value, 5 Yr. CAGR %	-16.24	9.08	-2.36	1.89	3.26
Common Equity, 5 Yr. CAGR %	10.08	13.62	11.59	11.12	10.81
Cash From Operations, 5 Yr. CAGR %	23.02	23.37	17.98	13.1	11.75
Capital Expenditures, 5 Yr. CAGR %	28.36	41.55	34.58	14.3	8.62
Levered Free Cash Flow, 5 Yr. CAGR %	17.24	17.36	15.92	9.77	15.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.33	16.12	14.77	10.5	15.47
Dividend Per Share, 5 Yr. CAGR %	7.96	11.63	14.87	15.54	15.47